Biochemical and molecular studies to investigate the synergistic anticancer effect of a combination of phosphodiesterase 5 inhibitors and sorafenib against hepatocellular carcinoma
Loading...
Date
item.page.authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
newline